Clinical Study

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy And Safety Of Lumateperone For The Treatment Of Major Depressive Episodes (Mdes) Associated With Bipolar I Or Bipolar II Disorder (Bipolar Depression) In Pediatric

Posted Date: Jan 7, 2025

  • Investigator: Melissa Delbello
  • Specialties: Adolescent Psychiatry/Psychology, Bipolar Disorder, Depression, Psychiatry/Psychology
  • Type of Study: Drug

The purpose of this clinical research study is to understand how effective and safe an investigational study drug called lumateperone is and whether it works when given to young people (10–17 years of age) with major depressive episodes associated with bipolar disorder.

Criteria:

Null

Keywords:

Depression, Bipolar Disorder, Pediatric

For More Information:

Maria Mastroianni
513 558-8950
maria.mastroianni@uc.edu